Comparing robotic platforms for kidney surgery outcomes
Comparison of Outcomes of Multiple Platforms for Assisted Robotic-Kidney
This study is testing which robotic system, DaVinci or Hugo, works better for kidney surgery by looking at complications and outcomes for patients with localized kidney tumors.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 18 Years to 90 Years |
| Sex | All |
| Sponsor | Azienda Ospedaliera Universitaria Integrata Verona Academic / other |
| Locations | 1 site (Verona, VR) |
| Trial ID | NCT06290427 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates postoperative complications associated with robotic-assisted partial nephrectomy using two surgical platforms: DaVinci and Hugo. Participants will undergo surgery with one of these platforms, and the study aims to identify differences in intra- and post-operative outcomes, including complications, oncological results, and technical aspects. The goal is to provide preliminary insights into the effectiveness and safety of these robotic systems in treating localized kidney tumors.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 to 90 with localized kidney tumors suitable for partial nephrectomy.
Not a fit: Patients who are not suitable for partial nephrectomy or who do not meet the age criteria will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved surgical outcomes and reduced complications for patients undergoing robotic kidney surgery.
How similar studies have performed: Other studies have explored robotic-assisted surgeries, but this specific comparison of platforms is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patient aged between 18 and 90 years old; * patient with localized kidney tumor suitable for partial nephrectomy; * patient able to understand and sign the informed consent; * patient compliance with the follow-up program. Exclusion Criteria: * patient who do not fall within the inclusion age range; * patient not suitable for partial nephrectomy; * patient unable to understand and sign the informed consent; * patient unable to follow the monitoring program; * patient refusal to participate to the study.
Where this trial is running
Verona, VR
- Urology Unit, AOUI Verona — Verona, Vr, Italy (Recruiting)
Study contacts
- Principal investigator: Alessandro AA Antonelli, MD — Azienda Ospedaliera Universitaria Integrata Verona
- Study coordinator: Alessandro AA Antonelli, MD
- Email: alessandro.antonelli@aovr.veneto.it
- Phone: +39 0458127701
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.